Mars Petcare on Tuesday announced the completion of its acquisition of Heska, which produces advanced veterinary diagnostic and specialty products.
Under the terms of the acquisition, which was announced on April 3, Mars agreed to acquire Heska for $120 per share.
Heska is now part of Mars Petcare’s Science & Diagnostics division, enabling Mars to accelerate research and development and expand access to diagnostics and technology to more veterinary professionals and pets, Mars said.
For the acquisition, Lazard served as Mars’ financial advisor; Skadden, Arps, Slate, Meagher & Flom acted as Mars’ legal advisor. BofA Securities and Piper Sandler served as Heska’s financial advisor; Gibson, Dunn & Crutcher acted as Heska’s legal advisor.
